• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

传染性克隆产生的 SARS-CoV-2 可导致感染 K18-Human ACE2 小鼠发生严重肺部疾病。

Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.

机构信息

Menzies Health Institute Queensland, Griffith University, Gold Coast Campus, Southport, Queensland, Australia.

Global Virus Network (GVN) Centre of Excellence in Arboviruses, Griffith University, Gold Coast, QLD, Australia.

出版信息

mBio. 2021 Apr 20;12(2):e00819-21. doi: 10.1128/mBio.00819-21.

DOI:10.1128/mBio.00819-21
PMID:33879586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8092263/
Abstract

Newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, which has caused extensive mortality and morbidity and wreaked havoc on socioeconomic structures. The urgent need to better understand SARS-CoV-2 biology and enable continued development of effective countermeasures is aided by the production of laboratory tools that facilitate SARS-CoV-2 research. We previously created a directly accessible SARS-CoV-2 toolkit containing user-friendly reverse genetic (RG) infectious clones of SARS-CoV-2. Here, using K18-human ACE2 (hACE2) mice, we confirmed the validity of RG-rescued SARS-CoV-2 viruses to reproduce the infection profile, clinical disease, and pathogenesis already established in mice infected with natural SARS-CoV-2 isolates, often patient derived. RG-rescued SARS-CoV-2-infected K18-hACE2 mice developed substantial clinical disease and weight loss by day 6 postinfection. RG-rescued SARS-CoV-2 was recovered from the lungs and brains of infected K18-hACE2 mice, and infection resulted in viral pneumonia with considerable changes in lung pathology, as seen previously with natural SARS-CoV-2 infection. In mice infected with RG-rescued SARS-CoV-2-mCherry, mCherry was detected in areas of lung consolidation and colocalized with clinically relevant SARS-CoV-2-assocated immunopathology. RG-rescued SARS-CoV-2 viruses successfully recapitulated many of the features of severe COVID-19 associated with the K18-hACE2 model of SARS-CoV-2 infection. With utility , the RG-rescued SARS-CoV-2 viruses will be valuable resources to advance numerous areas of SARS-CoV-2 basic research and COVID-19 vaccine development. To develop COVID-19 countermeasures, powerful research tools are essential. We produced a SARS-COV-2 reverse genetic (RG) infectious clone toolkit that will benefit a variety of investigations. In this study, we further prove the toolkit's value by demonstrating the utility of RG-rescued SARS-CoV-2 isolates. RG-rescued SARS-CoV-2 isolates reproduce disease signs and pathology characteristic of the K18-hACE2 mouse model of severe COVID-19 in infected mice. Having been validated as a model of severe COVID-19 previously using only natural SARS-CoV-2 isolated from patients, this is the first investigation of RG-rescued SARS-CoV-2 viruses in K18-hACE2 mice. The RG-rescued SARS-CoV-2 viruses will facilitate basic understanding of SARS-CoV-2 and the preclinical development of COVID-19 therapeutics.

摘要

新型严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)是正在发生的 2019 年冠状病毒病(COVID-19)大流行的病原体,它造成了广泛的死亡率和发病率,并破坏了社会经济结构。更好地了解 SARS-CoV-2 生物学并能够继续开发有效的对策的迫切需要,得益于生产有助于 SARS-CoV-2 研究的实验室工具。我们之前创建了一个直接可用的 SARS-CoV-2 工具包,其中包含 SARS-CoV-2 的用户友好型反向遗传(RG)感染性克隆。在这里,我们使用 K18-人血管紧张素转换酶 2(hACE2)小鼠,确认了 RG 拯救的 SARS-CoV-2 病毒能够重现已经在感染天然 SARS-CoV-2 分离株的小鼠中建立的感染谱、临床疾病和发病机制,这些分离株通常是从患者中获得的。感染 RG 拯救的 SARS-CoV-2 的 K18-hACE2 小鼠在感染后第 6 天出现严重的临床疾病和体重减轻。从感染 K18-hACE2 小鼠的肺部和大脑中回收了 RG 拯救的 SARS-CoV-2,感染导致病毒性肺炎,肺部病理学发生了很大变化,这与以前感染天然 SARS-CoV-2 时的情况相似。在感染 RG 拯救的 SARS-CoV-2-mCherry 的小鼠中,mCherry 检测到肺部实变区域,与临床上相关的 SARS-CoV-2 相关免疫病理学相关。RG 拯救的 SARS-CoV-2 病毒成功地再现了与 K18-hACE2 感染 SARS-CoV-2 模型相关的许多严重 COVID-19 的特征。由于其用途广泛,RG 拯救的 SARS-CoV-2 病毒将成为推进 SARS-CoV-2 基础研究和 COVID-19 疫苗开发的众多领域的宝贵资源。为了开发 COVID-19 对策,强大的研究工具是必不可少的。我们生产了一种 SARS-COV-2 反向遗传(RG)感染性克隆工具包,该工具包将有益于各种研究。在这项研究中,我们通过证明 RG 拯救的 SARS-CoV-2 分离株的用途,进一步证明了工具包的价值。RG 拯救的 SARS-CoV-2 分离株在感染小鼠中复制了与 K18-hACE2 小鼠严重 COVID-19 模型相关的疾病迹象和病理学特征。以前仅使用从患者中分离出的天然 SARS-CoV-2 对该模型进行了严重 COVID-19 的验证,这是首次在 K18-hACE2 小鼠中对 RG 拯救的 SARS-CoV-2 病毒进行研究。RG 拯救的 SARS-CoV-2 病毒将有助于深入了解 SARS-CoV-2 并促进 COVID-19 治疗的临床前开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/8092263/bf80ea1b0922/mBio.00819-21_f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/8092263/e864a4da802c/mBio.00819-21_f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/8092263/4468002fd564/mBio.00819-21_f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/8092263/8f5bb0d47991/mBio.00819-21_f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/8092263/67ce53d54c13/mBio.00819-21_f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/8092263/8266c5800aaa/mBio.00819-21_f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/8092263/bf80ea1b0922/mBio.00819-21_f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/8092263/e864a4da802c/mBio.00819-21_f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/8092263/4468002fd564/mBio.00819-21_f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/8092263/8f5bb0d47991/mBio.00819-21_f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/8092263/67ce53d54c13/mBio.00819-21_f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/8092263/8266c5800aaa/mBio.00819-21_f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/8092263/bf80ea1b0922/mBio.00819-21_f006.jpg

相似文献

1
Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.传染性克隆产生的 SARS-CoV-2 可导致感染 K18-Human ACE2 小鼠发生严重肺部疾病。
mBio. 2021 Apr 20;12(2):e00819-21. doi: 10.1128/mBio.00819-21.
2
SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.SARS-CoV-2 引起人类 ACE2 基因敲入小鼠肺部感染但不引起严重疾病。
J Virol. 2022 Jan 12;96(1):e0151121. doi: 10.1128/JVI.01511-21. Epub 2021 Oct 20.
3
The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.K18-Human ACE2 转基因小鼠模型对 SARS-CoV-2 病毒感染剂量的反应可重现非重症和重症 COVID-19。
J Virol. 2022 Jan 12;96(1):e0096421. doi: 10.1128/JVI.00964-21. Epub 2021 Oct 20.
4
Mouse-Adapted SARS-CoV-2 MA10 Strain Displays Differential Pulmonary Tropism and Accelerated Viral Replication, Neurodissemination, and Pulmonary Host Responses in K18-hACE2 Mice.鼠适应的 SARS-CoV-2 MA10 株在 K18-hACE2 小鼠中显示出不同的肺嗜性和加速的病毒复制、神经传播以及肺部宿主反应。
mSphere. 2023 Feb 21;8(1):e0055822. doi: 10.1128/msphere.00558-22. Epub 2023 Feb 2.
5
Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease.人恢复期血浆可保护K18-hACE2小鼠免受严重呼吸道疾病的侵害。
J Gen Virol. 2021 May;102(5). doi: 10.1099/jgv.0.001599.
6
Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice.经鼻腔接种 SARS-CoV-2 后 K18-hACE2 小鼠的神经侵袭和脑炎。
Viruses. 2021 Jan 19;13(1):132. doi: 10.3390/v13010132.
7
Establishment and characterization of an hhTMPRSS2 knock-in mouse model to study SARS-CoV-2.建立并鉴定 hhTMPRSS2 基因敲入小鼠模型以研究 SARS-CoV-2。
Front Immunol. 2024 Jul 10;15:1428711. doi: 10.3389/fimmu.2024.1428711. eCollection 2024.
8
Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.表达人血管紧张素转换酶 2 的仓鼠在接触 SARS-CoV-2 后会发展为严重疾病。
mBio. 2022 Feb 22;13(1):e0290621. doi: 10.1128/mbio.02906-21. Epub 2022 Jan 25.
9
Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.具有中等病理特征的肺特异性 SARS-CoV-2 感染的小鼠模型。
Front Immunol. 2022 Nov 15;13:1055811. doi: 10.3389/fimmu.2022.1055811. eCollection 2022.
10
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在人血管紧张素转换酶2(hACE2)转基因小鼠中的致病性。
Nature. 2020 Jul;583(7818):830-833. doi: 10.1038/s41586-020-2312-y. Epub 2020 May 7.

引用本文的文献

1
A single-dose intranasal live-attenuated codon deoptimized vaccine provides broad protection against SARS-CoV-2 and its variants.单剂鼻内接种减毒活疫苗可提供针对 SARS-CoV-2 及其变体的广泛保护。
Nat Commun. 2024 Aug 26;15(1):7225. doi: 10.1038/s41467-024-51535-y.
2
The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development.致死性 K18-hACE2 敲入小鼠模型模拟 COVID-19 的重症肺炎,可用于抗病毒药物的研发。
Emerg Microbes Infect. 2024 Dec;13(1):2353302. doi: 10.1080/22221751.2024.2353302. Epub 2024 May 26.
3
Improved survival of SARS COV-2-infected K18- mice treated with adenosine AR agonist.

本文引用的文献

1
A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research.一种基于质粒 DNA 的 SARS-CoV-2 反向遗传学系统和冠状病毒工具包,用于 COVID-19 研究。
PLoS Biol. 2021 Feb 25;19(2):e3001091. doi: 10.1371/journal.pbio.3001091. eCollection 2021 Feb.
2
Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis.SARS-CoV-2 患者的合并症:系统评价和荟萃分析。
mBio. 2021 Feb 9;12(1):e03647-20. doi: 10.1128/mBio.03647-20.
3
Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence.
用腺苷AR激动剂治疗的感染SARS-CoV-2的K18小鼠存活率提高。
Heliyon. 2023 Aug 18;9(8):e19226. doi: 10.1016/j.heliyon.2023.e19226. eCollection 2023 Aug.
4
A Rapid Method for Generating Infectious SARS-CoV-2 and Variants Using Mutagenesis and Circular Polymerase Extension Cloning.一种利用诱变和环状聚合酶延伸克隆快速生成传染性严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及其变体的方法。
Microbiol Spectr. 2023 Mar 6;11(2):e0338522. doi: 10.1128/spectrum.03385-22.
5
Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice.新型冠状病毒感染小鼠肺部的细胞因子和炎症脂质介质。
Front Immunol. 2022 Jun 24;13:893792. doi: 10.3389/fimmu.2022.893792. eCollection 2022.
6
The Delta SARS-CoV-2 Variant of Concern Induces Distinct Pathogenic Patterns of Respiratory Disease in K18-hACE2 Transgenic Mice Compared to the Ancestral Strain from Wuhan.Delta 变异株 SARS-CoV-2 引起的呼吸道疾病在 K18-hACE2 转基因小鼠中的发病模式与武汉原始株明显不同。
mBio. 2022 Jun 28;13(3):e0068322. doi: 10.1128/mbio.00683-22. Epub 2022 Apr 14.
7
Human-Immune-System (HIS) humanized mouse model (DRAGA: HLA-A2.HLA-DR4.Rag1KO.IL-2RγcKO.NOD) for COVID-19.用于 COVID-19 的人免疫系统 (HIS) 人源化小鼠模型 (DRAGA: HLA-A2.HLA-DR4.Rag1KO.IL-2RγcKO.NOD)。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2048622. doi: 10.1080/21645515.2022.2048622. Epub 2022 Mar 29.
8
Experimental Models of COVID-19.新型冠状病毒肺炎的实验模型。
Front Cell Infect Microbiol. 2022 Jan 5;11:792584. doi: 10.3389/fcimb.2021.792584. eCollection 2021.
9
Antibodies to the N-Terminal Domain of Angiotensin-Converting Enzyme (ACE2) That Block Its Interaction with SARS-CoV-2 S Protein.针对血管紧张素转换酶(ACE2)N 端结构域的抗体可阻断其与 SARS-CoV-2 S 蛋白的相互作用。
Dokl Biochem Biophys. 2022 Feb;502(1):1-4. doi: 10.1134/S160767292201001X. Epub 2021 Dec 4.
尽管血清阳性率很高,巴西玛瑙斯仍出现新冠病毒的卷土重来。
Lancet. 2021 Feb 6;397(10273):452-455. doi: 10.1016/S0140-6736(21)00183-5. Epub 2021 Jan 27.
4
Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK.南非严重急性呼吸综合征冠状病毒2变种501Y.V2传入英国。
J Infect. 2021 Apr;82(4):e8-e10. doi: 10.1016/j.jinf.2021.01.007. Epub 2021 Jan 17.
5
Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia.新型冠状病毒肺炎中受感染的巨噬细胞和 T 细胞之间的回路。
Nature. 2021 Feb;590(7847):635-641. doi: 10.1038/s41586-020-03148-w. Epub 2021 Jan 11.
6
Emergence of a new SARS-CoV-2 variant in the UK.英国出现新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变种。
J Infect. 2021 Apr;82(4):e27-e28. doi: 10.1016/j.jinf.2020.12.024. Epub 2020 Dec 28.
7
Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study.比较 COVID-19 和季节性流感的特征、发病率和死亡率:一项全国性、基于人群的回顾性队列研究。
Lancet Respir Med. 2021 Mar;9(3):251-259. doi: 10.1016/S2213-2600(20)30527-0. Epub 2020 Dec 17.
8
Emergence of a Highly Fit SARS-CoV-2 Variant.一种高度适应的严重急性呼吸综合征冠状病毒2变体的出现。
N Engl J Med. 2020 Dec 31;383(27):2684-2686. doi: 10.1056/NEJMcibr2032888. Epub 2020 Dec 16.
9
SARS-CoV-2 evades immune detection in alveolar macrophages.SARS-CoV-2 在肺泡巨噬细胞中逃避免疫检测。
EMBO Rep. 2020 Dec 3;21(12):e51252. doi: 10.15252/embr.202051252. Epub 2020 Oct 28.
10
Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.从单个细菌人工染色体中拯救 SARS-CoV-2。
mBio. 2020 Sep 25;11(5):e02168-20. doi: 10.1128/mBio.02168-20.